LG Group Chairman Koo Kwang-mo, center, listens to an explanation of the selection process of cells with enhanced anti-cancer functions for producing cell therapies at Dana-Farber Cancer Institute in Boston on Monday. [LG CORP.] LG Chairman Koo Kwang-mo wrapped up a four-day visit to the United States and Canada on Thursday, putting a spotlight on biopharmaceuticals and artificial intelligence technologies as the conglomerate group's future growth drivers. The latest move signifies LG's shifting focus toward AI, biopharmaceuticals and cleantech — which is referred to as the 'ABC' strategy by the company — alongside a bigger emphasis on global expansion.

https://n.news.naver.com/mnews/article/640/0000042516?sid=101

#naver